Comparison of ddI Versus Zidovudine in HIV-Infected Patients

NCT00000979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1500

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]